Pharmaron Beijing (03759) appoints Li Chengzong as the company's authorized representative.

date
21:57 20/08/2026
avatar
GMT Eight
Kanglong Chemical (03759) announced that Mr. Lou Xiaoqiang, a company director, will resign as the company's authorized representative under Listing Rule 3.05 due to a work reallocation, effective August 20, 2026. From the same date, the board has approved the appointment of Mr. Li Chengzong, a company director, to succeed Mr. Lou Xiaoqiang as the company's authorized representative. After resigning as the authorized representative, Mr. Lou Xiaoqiang will continue to serve as the company's Chief Operating Officer, President, and Executive Director, with no other changes to his authority and responsibilities.
Pharmaron Beijing (03759) announced that Mr. Lou Xiaoqiang, a director of the company, will step down from his position as the companys authorized representative under Listing Rule 3.05 due to adjustments in work responsibilities, effective August 20, 2026. From the same date, the Board of Directors has approved the appointment of Mr. Li Chengzong, a director of the company, to replace Mr. Lou Xiaoqiang as the company's authorized representative. After stepping down as the authorized representative, Mr. Lou Xiaoqiang will continue to serve as the Chief Operating Officer, President, and Executive Director of the company, with no other changes to his authority and responsibilities.